The global arthroscopy visualization systems market was about US$ 427.3 Million in 2021, with the global market estimated to surge ahead at a CAGR value of 7.1% to reach a valuation of US$ 902.5 Million by the end of 2032. The visualization systems are driving the global arthroscopy visualization systems market as of 2021.
Market Outlook:
| Data Points | Market Insight |
|---|---|
| Market Value 2021 | US$ 427.3 Million |
| Estimated market Value 2022 | US$ 453.8 Million |
| Estimated market Value 2032 | US$ 902.5 Million |
| CAGR of 2022 to 2032 | 7.1 % |
| Market share of Top 5 countries | 60.9 % |
| Key Market players | Arthrex, Inc., Stryker Corporation, Smith & Nephew Plc., CONMED Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, Johnson & Johnson |
Arthroscopes are thin fiber-optic scopes that enable visualization of the interior of joints, such as the knee, shoulder, wrist, hip, ankle, and elbow. The arthroscopic system is used in the minimally-invasive surgical procedures.
Arthroscopy is a minimally invasive surgery used to detect and treat joint problems. It permits a surgeon to view the joint without having to make a sizable incision. At a specific point during arthroscopy, surgeons can even repair joint damage using pencil-thin surgical instruments inserted through extremely small incisions.
In this operation, the surgeon makes a tiny incision and inserts a skinny tube with a fiber-optic video camera inside. A high-definition video display receives the view from inside the joint.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Overall, arthroscopy visualization systems market sales account for approximately 6.6% revenue share in the global arthroscopy products market, which was valued at around US$ 6.5 Billion, in 2021.
The global arthroscopy visualization systems market recorded a historic CAGR of 5.1% in the last nine years from 2012 to 2021.
One of the main factors driving the growth of the global market for arthroscopy visualization systems is the increase in the elderly population, who are considerably more susceptible to trauma, osteoarthritis, and other knee and joint-related disorders. Soft tissue degeneration and associated problems, particularly those of the knee, are influenced by aging. The elderly population makes up more than one-third of all hip and shoulder injuries worldwide.
For instance, the World Health Aging 2020 highlights published by the UN Department of Economic and Social Affairs indicated that there were 727 million individuals who were either 65 or older worldwide in October 2020, making up 9.3% of the entire world's population. By 2050, the aging population is projected to grow by 16% or over 1.5 billion people.
Furthermore, the development of technologically advanced instruments, implants, and equipment for arthroscopy surgeries with arthroscopy visualization systems will foster growth worldwide, as will the rising number of arthroscopic procedures as a result of the rise in sports injuries, ligament tears, meniscus tears, and other similar reasons.
Osteoarthritis is more common in the elderly and obese population, which will raise the demand for arthroscopy visualization systems. The Centers for Disease Control and Prevention (CDC) estimated that in 2015, osteoarthritis impacted 32.5 million individuals in the United States and about 54.4 million people overall.
By 2040, this figure is projected to increase to 78 million. Obesity triples the likelihood of developing knee osteoarthritis, making it a significant risk factor.
The aforementioned factors are expected to serve as probable market drivers for the global arthroscopy visualization systems market and help the market to expand significantly in the forecast period.
Due to the numerous advantages that minimally invasive surgical procedures have over open surgeries, including small surgical incisions, lower hospitalization costs, and fewer post-operative complications, minimally invasive surgeries are becoming increasingly popular among surgeons.
The market for arthroscopy visualization systems is likely to see significant growth potential due to rising preference and acceptance of minimally invasive and cost-effective procedures employing arthroscopic instruments.
Opportunities for developing technologies like improvised visualization equipment in the form of high-definition cameras or autoclavable cameras, and improved suturing techniques, are projected to arise from the growth of sports injuries and medicine, particularly arthroscopy.
Additionally, advanced technologies in hip arthroscopies, such as computer-assisted surgeries and virtual reality surgical simulation training before actual operations, have increased the precision of pre-operative planning and are anticipated to broaden the scope of hip arthroscopy, which will favorably impact the market for arthroscopy visualization systems.
The abovementioned factors are capable of acting as lucrative opportunities for manufacturers operating in the arthroscopy visualization systems market.
Principal Consultant
The market for arthroscopy visualization systems and products was negatively impacted by the coronavirus outbreak. Due to cancellations of planned operations at various medical facilities, due to travel limitations that have an impact on logistics and product supply, there has been an increase in interruptions at production sites, in the supply chain, and in other commercial activities.
A rise in product recalls is one of the reasons restricting the market for arthroscopy visualization systems. A product recall is a process of collecting every faulty item that has been sold or is currently on the market.
The expenses of all repairs and replacements must be covered by the manufacturer when it recalls a product because of a problem. The replacement cost for many products could be in the millions of dollars, which limits the market's growth as well as that of a company.
For instance, in Jan 2022, the FDA recalled a product called Camera Control Unit (CCU) of Stryker Corporation on the charge of medical safety notification January. The images on the monitor obtained were upside-down in the wrong position due to a software flaw in the camera control unit (CCU). Conversion to an open operation, extra medical treatment, or revision surgery all included the risk of negative outcomes.
The USA accounted for US$ 137.3 Million withholding the majority of the global market share of about 32.1% by the end of 2021. The American Orthopedic Society for Sports Medicine, the Arthritis Foundation, and the Arthroscopy Association of USA are a few of the organizations that receive major funding and assistance from the USA Federal Government for orthopedic care and treatment.
Due to the USA FDA's supportive environment and the country's manufacturers' extensive Drivers, Restraints, Opportunities, and Threats efforts, the USA is the largest market in the world for arthroscopy visualization systems.
Germany has driven the European market by holding the majority of the regional market share of about 33.9% and achieving a valuation of US$ 45.9 Million at end of 2021. The market is being driven by an increase in the number of urgent care patients with long-term illnesses, an increase in Level 3 grade injuries among the aging population & athletes, and an increase in the number of accidents countrywide.
The market for arthroscopy visualization systems is anticipated to develop as a result of the increasing incidence of hip and spine surgeries.
China dominated the regional market by reaching a valuation of US$ 22.66 Million and is expected to grow over a CAGR of 8.5% over the forecast period. The market’s expansion can be attributed to the country's growing medical tourism industry.
The market in China is also anticipated to be driven by a rising aging population, increased awareness of sports-related injuries, and rising disposable income. The global market for arthroscopy visualization is expanding as a result of rising demand for minimally invasive procedures and low levels of postoperative complications.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product, the visualization systems have driven the global market by holding the majority of the market share of about 48.8% as of 2021. Smaller incisions, lower soft tissue trauma, less post-operative discomfort, quicker healing times, and lower infection rates are some of the aspects that contribute to the product’s market expansion.
By application, knee arthroscopy is leading the segment for the global market by accounting for US$ 131.0 Million by the end of 2021. With the increasing geriatric population, bone-related issues are also emerging, especially the rising prevalence of osteoarthritis, as well as an increasing number of sports-related injuries, which have driven this segment.
By end user, orthopedic clinics have led the global market by holding a majority of the market share of about 31.1% as of 2021. The availability of advanced healthcare infrastructure and the presence of a large patient pool are some of the major factors contributing to the market growth of orthopedic centers.
The expansion of manufacturing facilities is a top priority for manufacturers of arthroscopy visualization systems since it will increase their production capacity. the exploration of new markets and access to a sizable customer base, will offer companies prospects for expansion on a global scale.
To strengthen their position in the global market for arthroscopy visualization systems, the major manufacturers are launching a variety of products and doing research and development activities that concentrate on orthopedic surgical procedures.
For instance:
Similarly, recent developments related to companies manufacturing arthroscopy visualization systems, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA). |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Product, Application, End User, and Regions |
| Key Companies Profiled | Arthrex, Inc., Stryker Corporation, Smith & Nephew Plc., CONMED Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, and Johnson & Johnson |
| Pricing | Available upon Request |
The global arthroscopy visualization systems market is worth US$ 427.3 Million at end of 2021.
The arthroscopy visualization systems market is expected to reach US$ 902.5 Million by end of 2032 at a CAGR of 7.1%.
Technological advancements in arthroscopy visualization systems, and increasing bone and joint-related issues among people, leading to an increase in the prevalence of arthritis and chronic illness, are some of the key factors that drive this market.
The North American region has the highest market share of about 34.1% by the end of 2021 in the global arthroscopy visualization systems market.
India accounted for about 3.9% of the global market share in the 2021 arthroscopy visualization systems market.
The USA, China, Germany, the United Kingdom, and India are the top five countries, which are expected to drive demand in the arthroscopy visualization systems market.
Arthrex Inc., Stryker Corporation, Smith & Nephew Plc., CONMED Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, and Johnson & Johnson, are some of the key players in the arthroscopy visualization systems industry.
From 2012 to 2021, the market for arthroscopy visualization systems devices expanded at the rate of 5.1%.
China accounted for 55.6% of the market share at the end of 2021 in the East Asian market.
Germany displayed a market share of around 33.9% in 2021 in the European arthroscopy visualization systems market.
1. Executive Summary | Arthroscopy Visualization Systems Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmaps
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, by Region
4.2. Key Promotional Strategies By Manufacturers
4.3. Value Chain Analysis
4.4. Reimbursement Scenario
4.5. Regulatory Approval
4.6. Product Adoption Analysis
4.7. Installed Based Scenario
4.8. PESTEL Analysis
4.9. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Arthroscopy Products Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Cost of Visualization Systems
5.2.3. Demand for Arthroscopy Procedures
5.2.4. Availability of the Better Healthcare Infrastructure
5.2.5. Prevalence of Arthritis
5.2.6. Growing Awareness About Bone Health
5.2.7. Government Funding
5.2.8. Rising Geriatric Population
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Market Volume (Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2012 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis, by Products
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Market Demand (in Value US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Product, 2012 to 2021
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, by Product, 2022 to 2032
10.3.1. Arthroscopes
10.3.2. Visualization Systems
10.3.3. Consumables & Accessories
10.4. Market Attractiveness Analysis, by Product
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, by Product, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Product, 2022 to 2032
11.3.1. Knee Arthroscopy
11.3.2. Hip Arthroscopy
11.3.3. Shoulder Arthroscopy
11.3.4. Others
11.4. Market Attractiveness Analysis, by Application
12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by End User, 2022 to 2032
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Orthopedic Clinics
12.3.4. Others
12.4. Market Attractiveness Analysis, by End User
13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2012 to 2021
13.3. Current and Future Market Value (US$ Million) and Volume (Units) Projections, 2022 to 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis, by Region
14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
14.3.1. By Country
14.3.1.1. USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country-Level Analysis & Forecast
14.7.1. USA Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Application
14.7.1.2.3. By End User
14.7.2. Canada Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Application
14.7.2.2.3. By End User
15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country-Level Analysis & Forecast
15.7.1. Mexico Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By Application
15.7.1.2.3. By End User
15.7.2. Brazil Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Application
15.7.2.2.3. By End User
15.7.3. Argentina Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By Application
15.7.3.2.3. By End User
16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. United Kingdom
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country-Level Analysis & Forecast
16.7.1. Germany Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Application
16.7.1.2.3. By End User
16.7.2. Italy Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Application
16.7.2.2.3. By End User
16.7.3. France Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By Application
16.7.3.2.3. By End User
16.7.4. United Kingdom Market Analysis
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
16.7.4.2.1. By Product
16.7.4.2.2. By Application
16.7.4.2.3. By End User
16.7.5. Spain Market Analysis
16.7.5.1. Introduction
16.7.5.2. Market Analysis and Forecast, by Market Taxonomy
16.7.5.2.1. By Product
16.7.5.2.2. By Application
16.7.5.2.3. By End User
16.7.6. BENELUX Market Analysis
16.7.6.1. Introduction
16.7.6.2. Market Analysis and Forecast, by Market Taxonomy
16.7.6.2.1. By Product
16.7.6.2.2. By Application
16.7.6.2.3. By End User
16.7.7. Russia Market Analysis
16.7.7.1. Introduction
16.7.7.2. Market Analysis and Forecast, by Market Taxonomy
16.7.7.2.1. By Product
16.7.7.2.2. By Application
16.7.7.2.3. By End User
17. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Distribution Channel (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country-Level Analysis & Forecast
17.7.1. China Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Application
17.7.1.2.3. By End User
17.7.2. Japan Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Application
17.7.2.2.3. By End User
17.7.3. South Korea Market Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By Application
17.7.3.2.3. By End User
18. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
18.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country-Level Analysis & Forecast
18.7.1. India Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By Application
18.7.1.2.3. By End User
18.7.2. Indonesia Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By Application
18.7.2.2.3. By End User
18.7.3. Malaysia Market Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
18.7.3.2.1. By Product
18.7.3.2.2. By Application
18.7.3.2.3. By End User
18.7.4. Thailand Market Analysis
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
18.7.4.2.1. By Product
18.7.4.2.2. By Application
18.7.4.2.3. By End User
19. Oceania Market 2012 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
19.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Country-Level Analysis & Forecast
19.7.1. Australia Market Analysis
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
19.7.1.2.1. By Product
19.7.1.2.2. By Application
19.7.1.2.3. By End User
19.7.2. New Zealand Market Analysis
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
19.7.2.2.1. By Product
19.7.2.2.2. By Application
19.7.2.2.3. By End User
20. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
20.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. North Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By End User
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Country-Level Analysis & Forecast
20.7.1. GCC Countries Market Analysis
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast, by Market Taxonomy
20.7.1.2.1. By Product
20.7.1.2.2. By Application
20.7.1.2.3. By End User
20.7.2. Turkey Market Analysis
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast, by Market Taxonomy
20.7.2.2.1. By Product
20.7.2.2.2. By Application
20.7.2.2.3. By End User
20.7.3. South Africa Market Analysis
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast, by Market Taxonomy
20.7.3.2.1. By Product
20.7.3.2.2. By Application
20.7.3.2.3. By End User
20.7.4. North Africa Market
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast, by Market Taxonomy
20.7.4.2.1. By Product
20.7.4.2.2. By Application
20.7.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis, by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Johnson & Johnson
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Product Strategy
22.3.1.6.3. Channel Strategy
22.3.2. Arthrex, Inc.
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Product Strategy
22.3.2.6.3. Channel Strategy
22.3.3. Stryker Corporation
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Product Strategy
22.3.3.6.3. Channel Strategy
22.3.4. Smith & Nephew Plc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Product Strategy
22.3.4.6.3. Channel Strategy
22.3.5. CONMED Corporation
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Product Strategy
22.3.5.6.3. Channel Strategy
22.3.6. KARL STORZ GmbH & Co. KG
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Product Strategy
22.3.6.6.3. Channel Strategy
22.3.7. Olympus Corporation
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Product Strategy
22.3.7.6.3. Channel Strategy
22.3.8. Richard Wolf GmbH
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Product Strategy
22.3.8.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Arthroscopy Visualization Systems Market
